CAS 41931-13-9|LCS-1

Introduction:Basic information about CAS 41931-13-9|LCS-1, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameLCS-1
CAS Number41931-13-9Molecular Weight255.10000
Density1.39g/cm3Boiling Point339.6ºC at 760 mmHg
Molecular FormulaC11H8Cl2N2OMelting Point/
MSDSUSAFlash Point159.2ºC
Symbol
GHS06
Signal WordDanger

Names

Name4,5-dichloro-2-(3-methylphenyl)pyridazin-3-one
SynonymMore Synonyms

LCS-1 BiologicalActivity

DescriptionLCS-1 is a superoxide dismutase 1 (SOD1) inhibitor. LCS-1 inhibits SOD1 activity with an IC50 value of 1.07 μM. LCS-1 induces the early- and late-stage apoptosis of multiple myeloma (MM.1S) cells[1][2][3].
Related CatalogSignaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>Cancer
Target

SOD1:1.07 μM (IC50)

In VitroLCS-1 (1-10000 nM; 24 hours) has selective cytotoxicity towards bloom syndrome gene product (BLM) -proficient and BLM-deficient HCT116 cells[1]. LCS-1 shows growth inhibitory effect on 10/27 adenocarcinoma cell lines (median IC50=0.20 μM; such as H23, H2347, HCC827 cell lines) and normal human bronchial epithelial (NHBE) cells (IC50=2.66 μM)[2]. LCS-1 (0, 1.25, 2 μM; 4 h) in a concentration-dependent manner triggers significant inhibition of SOD1 enzymatic activity in multiple myeloma (MM) cells[3]. LCS-1 (0, 1.25, 2.5, 5 μM; 48 h) in a dose-dependent manner reduces the viability of various MM cell lines, including MM.1R (Dexamethasone-resistant), Dox40 (Doxorubicin-resistant), or LR5 (Melphalan-resistant) cell lines[3]. LCS-1 (48 h) has IC50 values of 2.5 and 4.6 μM for cell viability of ANBL6-WT (Bortezomib-sensitive) and ANBL6-BR (Bortezomib- resistant) cells, respectively[3]. LCS-1 (1.25 μM; 16 h) induces a significant increase in ROS levels and O2− levels in MM.1S cells[3]. LCS-1 (1.25 μM; 16 h) shows a significant decrease in GSH/GSSG ratio in MM.1S cells[3]. LCS-1 (1.25 μM; 24h) induces the release of mitochondrial cytochrome-c into the cytosol, and enriches the proteins (HSP60/CLPP) mediating mtUPR signaling in MM.1S cells[3]. LCS-1-induced O2− (1.25 μM; 5 h) triggers a marked decrease in both RP2CP and RP1CP forms of 26S proteasomes[3]. LCS-1 (2 μM; 16 h) induces the early- and late-stage apoptosis of MM.1S cells[3]. LCS-1 (0, 0.5, 1, 1.5, 2 μM) upregulates p53/p21 signaling, as well as downregulates survival pathway proteins MCL-1, BclxL, or c-Myc in MM.1S cells[3]. LCS-1 (0, 4, 8, 16, 24 h; 2 μM) shows a rapid and robust induction of mitochondrial unfolded protein response (UPR) proteins (BIP, PERK, phosphorylated eIF2α, or a lectin protein calnexin) in MM.1S and ANBL6-BR cells[3]. Cell Viability Assay[1] Cell Line: BLM-proficient and BLM-deficient HCT116 cells Concentration: 1-10000 nM Incubation Time: 24 hours Result: Had IC50 values of 1462 nM and 24.92 nM for the viability of BLM-proficient and BLM-deficient HCT116 cells, respectively. Western Blot Analysis[3] Cell Line: MM.1S and ANBL6-BR cells Concentration: 2 μM Incubation Time: 16 hours Result: Decreased the expression of cell-cycle regulatory proteins (cyclin-B1, CDC25C, and CDC2). Western Blot Analysis[3] Cell Line: MM.1S cells Concentration: 0, 0.5, 1, 1.5, 2 μM Incubation Time: Result: Upregulated p53/p21 signaling, as well as downregulated survival pathway proteins MCL-1, BclxL, or c-Myc. Western Blot Analysis[3] Cell Line: MM.1S cells Concentration: 2 μM Incubation Time: 0, 4, 8, 16, 24 hours Result: Showed a rapid and robust induction of UPR proteins (BIP, PERK, phosphorylated eIF2α, or a lectin protein calnexin).
In VivoLCS-1 (20 mg/kg; i.p. every other day for 14 days) inhibits MM growth and prolongs host survival in MM.1S-bearing mice[3]. Animal Model: 5-week-old female CB17 SCID mice (MM.1S tumors volume=100 mm3)[3] Dosage: 20 mg/kg (diluted in saline) Administration: Intraperitoneal injections; treated on an every other day schedule for 14 days Result: Inhibited MM growth and prolongs host survival.
References

[1]. Gupta A, et al. Nanocarrier Composed of Magnetite Core Coated with Three Polymeric Shells Mediates LCS-1 Delivery for Synthetic Lethal Therapy of BLM-Defective Colorectal Cancer Cells. Biomacromolecules. 2018 Mar 12;19(3):803-815.

[2]. Somwar R, et al. Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines. Proc Natl Acad Sci U S A. 2011;108(39):16375-16380.

[3]. Du T, et al. Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13. Leukemia. 2021 Feb;35(2):550-561.

Chemical & Physical Properties

Density1.39g/cm3
Boiling Point339.6ºC at 760 mmHg
Molecular FormulaC11H8Cl2N2O
Molecular Weight255.10000
Flash Point159.2ºC
Exact Mass254.00100
PSA34.89000
LogP2.84770
Appearance of Characterswhite to beige
Index of Refraction1.627
InChIKeySYUPLLHVMCLXEM-UHFFFAOYSA-N
SMILESCc1cccc(-n2ncc(Cl)c(Cl)c2=O)c1
Storage condition2-8°C
Water SolubilityDMSO: soluble10mg/mL (clear solutikon, warmed)

Safety Information

Symbol
GHS06
Signal WordDanger
Hazard StatementsH301-H319
Precautionary StatementsP301 + P310-P305 + P351 + P338
Hazard CodesT,Xi
Risk Phrases25-36
Safety Phrases26-45
RIDADRUN 2811 6.1 / PGIII
HS Code2933990090

Customs

HS Code2933990090
Summary2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles1

More Articles
Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.

J. Biol. Chem. 289(41) , 28660-75, (2014)

The cadmium-transformed human lung bronchial epithelial BEAS-2B cells exhibit a property of apoptosis resistance as compared with normal non-transformed BEAS-2B cells. The level of basal reactive oxyg...

Synonyms

4,5-dichloro-2-m-tolyl-2H-pyridazin-3-one
4,5-Dichlor-2-m-tolyl-pyridazin-3-on
4,5-Dichloro-2-(3-methylphenyl)-3(2H)-pyridazinone
pyridazinone,2-46
4,5-Dichloro-2-m-tolylpyridazin-3(2H)-one
CAS 132178-78-0|1,5-dibromonaphthalene-2,6-diol
CAS 1163248-54-1|(5-Methyl-1H-pyrazol-3-yl)boronic acid
Recommended......
TOP